Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMYD2 | Q9NRG4 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
| ▸ | PRKCA | P17252 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17904279 | 0.88 | SMYD2 (0.35) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL17822610 | 0.86 | PRKCA (0.37) | SMYD2CYP3A4HTTSMN1; SMN2PRKCA | |
| SCHEMBL17822574 | 0.86 | PRKCA (0.37) | SMYD2CYP3A4HTTSMN1; SMN2PRKCA | |
| SCHEMBL17822499 | 0.86 | PRKCA (0.37) | SMYD2CYP3A4HTTSMN1; SMN2PRKCA | |
| SCHEMBL2963838 | 0.75 | CA1 (0.31) | CA1CA9PRKCA | |
| SCHEMBL598237 | 0.75 | CA1 (0.31) | CA1CA9PRKCA | |
| SCHEMBL2963840 | 0.75 | CA1 (0.31) | CA1CA9PRKCA | |
| SCHEMBL598238 | 0.75 | CA1 (0.31) | CA1CA9PRKCA | |
| SCHEMBL598239 | 0.75 | CA1 (0.31) | CA1CA9PRKCA | |
| SCHEMBL1739798 | 0.74 | SMYD2 (0.41) | SMYD2CYP3A4HTTSMN1; SMN2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5874464-A | ANTAGONIST OF PROTEIN KINASE C | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-02-23 | — | — | US | disclosed |